← Back

Wire · opportunities

Is Your Clinical Trial Enrolling the Right Patients? Q&A with Jen Lamppa

Published

24 September 2026

Topic

opportunities

◆ Sectors

Biotech

◆ Geography

United States

◆ Source

Read at pharmexec.com →

◆ Verified

Fusion42 · 24 September 2026 · Fusion42 review

FDA's pilot program and guidance promote using real-world data (RWD) to improve clinical trial patient recruitment accuracy and shorten early-stage drug trial timelines, encouraging pharma and biotech to adjust recruitment models accordingly.

This Wire brief sits within Fusion42's coverage of Biotech, and 1 source has reported it between 18 Sep 2026 and 24 Sep 2026.

◆ ◆ The Wire takeaway

You must redesign your trial recruitment strategies around validated patient data rather than relying on self-reports. This shift opens an opportunity to reduce enrolment errors and accelerate trial starts by integrating real-world data effectively.

◆ Coverage

1 source · first reported 18 Sep 2026 · latest 24 Sep 2026

◆ Related on Wire

◆ Topics

Biotechclinical-trialsreal-world-datafda-guidancepatient-recruitmentdrug-development